These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


487 related items for PubMed ID: 11438066

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bilateral Rhino-Orbital-Cerebral Mucormycosis.
    Teixeira BM, Dias MQ, Castela G.
    JAMA Ophthalmol; 2024 Jul 01; 142(7):e236486. PubMed ID: 39023643
    [Abstract] [Full Text] [Related]

  • 26. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z.
    J Clin Microbiol; 2006 Mar 01; 44(3):892-8. PubMed ID: 16517873
    [Abstract] [Full Text] [Related]

  • 27. [Rhino-orbital zygomycosis].
    Djokic M, Bojic I, Mikic D, Ivanovic A, Drincic R, Markovic Lj, Bulajic N, Mladenovic T.
    Vojnosanit Pregl; 2001 Mar 01; 58(5):551-6. PubMed ID: 11769421
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    Guimarães JA, Moura FC.
    Arq Bras Oftalmol; 2022 Mar 01; 85(1):77-81. PubMed ID: 34468552
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin.
    Ogawa T, Takezawa K, Tojima I, Shibayama M, Kouzaki H, Ishida M, Okabe H, Shimizu T.
    Auris Nasus Larynx; 2012 Apr 01; 39(2):224-8. PubMed ID: 21592699
    [Abstract] [Full Text] [Related]

  • 35. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
    Jeevanan J, Gendeh BS, Faridah HA, Vikneswaran T.
    Med J Malaysia; 2006 Mar 01; 61(1):106-8. PubMed ID: 16708746
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.
    Raj A, Gupta V, Krishnamoorthi S, Kaur H, Saini V.
    Indian J Ophthalmol; 2024 Oct 01; 72(10):1519-1523. PubMed ID: 39331447
    [No Abstract] [Full Text] [Related]

  • 38. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV, Gopinathan Nair A, Hegde R, Vithalani N, Desai S, Adulkar N, Kamal S, Mittal R, Bradoo RA.
    Ophthalmic Plast Reconstr Surg; 2024 Oct 01; 37(5):488-495. PubMed ID: 34314399
    [Abstract] [Full Text] [Related]

  • 39. Eye for an eye: near-fatal outcome of fungal infection in a young, diabetic girl.
    Vos FI, Reitsma S, Adriaensen GFJPM, Fokkens WJ.
    BMJ Case Rep; 2018 Apr 17; 2018():. PubMed ID: 29666080
    [Abstract] [Full Text] [Related]

  • 40. Rhino-orbital mucormycosis and aspergillosis: differences in outcome, clinical and imaging characteristics.
    Nithyanandam S, Correa MA.
    Eur Arch Otorhinolaryngol; 2010 Jan 17; 267(1):161-2. PubMed ID: 19890658
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.